Raza Ur Rehman’s Commentary on Fitusiran for the Management of Hemophilia A and B To Be Published
Raza Ur Rehman, Bachelor of Medicine and Surgery at Shaikh Khalifa bin Zayed Al Nahyan Medical and Dental College, shared on LinkedIn:
”I am pleased to share that my commentary article on Fitusiran, a first-in-class RNA interference (RNAi) therapy for the management of Hemophilia A and Hemophilia B, has been accepted for publication in Health Science Reports (Wiley).
This commentary discusses the evolving role of Fitusiran in rebalancing hemostasis and highlights its clinical significance in the current and future landscape of hemophilia management.
I am grateful to the editorial team at Health Science Reports for their efficient handling of the manuscript and the opportunity to contribute to the scientific discourse in this field.”
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation
-
Aug 22, 2026, 07:35Archil Jaliashvili: The Real Battle Is Not About Blood Volume — It Is About Oxygen
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study